Neurosense Therapeutics Ltd. (NRSN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neurosense Therapeutics Ltd. has entered into a standby equity purchase agreement with YA II PN, LTD. to sell up to $30 million in ordinary shares, which are traded on the Nasdaq under the symbol ‘NRSN.’ This agreement allows the company to issue and sell shares at its discretion, providing financial flexibility to support its business operations.
For further insights into NRSN stock, check out TipRanks’ Stock Analysis page.